NO176761C - Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrerInfo
- Publication number
- NO176761C NO176761C NO902109A NO902109A NO176761C NO 176761 C NO176761 C NO 176761C NO 902109 A NO902109 A NO 902109A NO 902109 A NO902109 A NO 902109A NO 176761 C NO176761 C NO 176761C
- Authority
- NO
- Norway
- Prior art keywords
- denotes
- preparation
- hydrogen
- therapeutically active
- phosphinic acids
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title abstract 2
- 125000004103 aminoalkyl group Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 206010013754 Drug withdrawal syndrome Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 206010008129 cerebral palsy Diseases 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000018198 spasticity Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/36—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Luminescent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898911017A GB8911017D0 (en) | 1989-05-13 | 1989-05-13 | Substituted aminoalkylphosphinic acids |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO902109D0 NO902109D0 (no) | 1990-05-11 |
| NO902109L NO902109L (no) | 1990-11-14 |
| NO176761B NO176761B (no) | 1995-02-13 |
| NO176761C true NO176761C (no) | 1995-05-24 |
Family
ID=10656689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO902109A NO176761C (no) | 1989-05-13 | 1990-05-11 | Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0399949B1 (sv) |
| JP (1) | JP2930366B2 (sv) |
| KR (1) | KR0159501B1 (sv) |
| AT (1) | ATE121095T1 (sv) |
| AU (1) | AU629335B2 (sv) |
| CA (1) | CA2016631C (sv) |
| DD (1) | DD294265A5 (sv) |
| DE (1) | DE69018514T2 (sv) |
| DK (1) | DK0399949T3 (sv) |
| ES (1) | ES2070303T3 (sv) |
| FI (1) | FI94416C (sv) |
| GB (1) | GB8911017D0 (sv) |
| GR (1) | GR3015770T3 (sv) |
| HR (1) | HRP940178A2 (sv) |
| HU (1) | HU206885B (sv) |
| IE (1) | IE66165B1 (sv) |
| IL (1) | IL94317A (sv) |
| MX (1) | MX20639A (sv) |
| NO (1) | NO176761C (sv) |
| NZ (1) | NZ233647A (sv) |
| PT (1) | PT94014B (sv) |
| SI (1) | SI9010917B (sv) |
| YU (1) | YU91790A (sv) |
| ZA (1) | ZA903611B (sv) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0767174A1 (de) * | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Neue Aminoalkanphosphinsäuren und ihre Salze |
| PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| CN1309659A (zh) | 1998-07-15 | 2001-08-22 | 哈桑·朱马 | 有机磷化合物及其用途 |
| GB9906882D0 (en) * | 1999-03-25 | 1999-05-19 | Novartis Ag | Organic compounds |
| SE9904508D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| US7319095B2 (en) | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| AR033779A1 (es) | 2001-06-08 | 2004-01-07 | Astrazeneca Ab | Compuestos utiles en la enfermedad de reflujo |
| SE0102055D0 (sv) * | 2001-06-08 | 2001-06-08 | Astrazeneca Ab | New Compounds |
| PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| KR20080087852A (ko) | 2005-12-23 | 2008-10-01 | 아스트라제네카 아베 | Ｇａｂａ-ｂ 수용체 조절제 |
| JP2009521428A (ja) | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | 胃腸疾患治療用のイミダゾール誘導体 |
| DE102008056228A1 (de) * | 2008-11-06 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, deren Salze und Ester und ihre Verwendung |
| DE102008056339A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| WO2012050907A2 (en) | 2010-09-28 | 2012-04-19 | The Regents Of The University Of California | Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3311475C1 (de) * | 1983-03-29 | 1984-08-16 | Siemens AG, 1000 Berlin und 8000 München | Mikroprogramm-Steuereinrichtung |
| DE3312165A1 (de) * | 1983-04-02 | 1984-10-04 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von phosphinothricin |
| GB8728483D0 (en) * | 1987-12-04 | 1988-01-13 | Ciba Geigy Ag | Chemical compounds |
| GB8820266D0 (en) * | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
-
1989
- 1989-05-13 GB GB898911017A patent/GB8911017D0/en active Pending
-
1990
- 1990-05-07 AU AU54809/90A patent/AU629335B2/en not_active Ceased
- 1990-05-07 IL IL94317A patent/IL94317A/xx not_active IP Right Cessation
- 1990-05-08 ES ES90810346T patent/ES2070303T3/es not_active Expired - Lifetime
- 1990-05-08 AT AT90810346T patent/ATE121095T1/de not_active IP Right Cessation
- 1990-05-08 DK DK90810346.8T patent/DK0399949T3/da active
- 1990-05-08 DE DE69018514T patent/DE69018514T2/de not_active Expired - Fee Related
- 1990-05-08 EP EP90810346A patent/EP0399949B1/en not_active Expired - Lifetime
- 1990-05-09 MX MX2063990A patent/MX20639A/es unknown
- 1990-05-10 SI SI9010917A patent/SI9010917B/sl unknown
- 1990-05-10 YU YU91790A patent/YU91790A/sh unknown
- 1990-05-11 NZ NZ233647A patent/NZ233647A/en unknown
- 1990-05-11 CA CA002016631A patent/CA2016631C/en not_active Expired - Lifetime
- 1990-05-11 ZA ZA903611A patent/ZA903611B/xx unknown
- 1990-05-11 PT PT94014A patent/PT94014B/pt not_active IP Right Cessation
- 1990-05-11 HU HU903012A patent/HU206885B/hu not_active IP Right Cessation
- 1990-05-11 FI FI902368A patent/FI94416C/sv not_active IP Right Cessation
- 1990-05-11 KR KR1019900006687A patent/KR0159501B1/ko not_active IP Right Cessation
- 1990-05-11 IE IE171690A patent/IE66165B1/en not_active IP Right Cessation
- 1990-05-11 DD DD90340576A patent/DD294265A5/de not_active IP Right Cessation
- 1990-05-11 NO NO902109A patent/NO176761C/no not_active IP Right Cessation
- 1990-05-14 JP JP2121395A patent/JP2930366B2/ja not_active Expired - Fee Related
-
1994
- 1994-03-18 HR HRP-917/90A patent/HRP940178A2/hr not_active Application Discontinuation
-
1995
- 1995-04-13 GR GR950400747T patent/GR3015770T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176761C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer | |
| NZ303251A (en) | Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy | |
| IT1256345B (it) | Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
| HUT44001A (en) | Process for producing new phenoxy-acetamide derivatives and pharmaceutical compositions containing them as active components | |
| MA26457A1 (fr) | Vinylpyrrolidone-cephalosporines a substituants basiques, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
| FI951414A (sv) | Förfarande för framställning av klavulansyra | |
| ZA904443B (en) | N-heteroaryl-purin-6-amines,a process for their preparation and their use as medicaments | |
| MY111702A (en) | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative | |
| ES8103756A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| NO175369C (no) | Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt salt | |
| DE3782548D1 (de) | Ergolin-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| KR960017669A (ko) | 양쪽성 3환식 화합물 | |
| NZ308024A (en) | The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine | |
| DK634686D0 (da) | Dioxahexensyrer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| DE3381885D1 (de) | Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| FI901994A0 (sv) | Förfarande för framställning av terapeutiskt användbara aminosubstituerade tvärbundna azabicykliska kinolonkarboxylsyror och estrar av dessa | |
| TH1354A (th) | ออพติคัลลี่ แอคตีฟ 1-(6-เมทธอกซี-2-แนพซิล)-2-(อัลคอกซิคาร์บอนิล) อะมิโน-1-โพรพะโนน อนุพันธุ์ต่างๆ และพวกสารฮาโลของมัน และกรรมวิธีการผลิตสารเหล่านี้ | |
| JO1870B1 (en) | CO2 derivatives - pyridinyl benzimidazole innovative | |
| JPS5663972A (en) | Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt | |
| TW263509B (sv) | ||
| JO1871B1 (en) | Innovative substituted benzimidazole compounds | |
| TH364A (th) | สารประกอบชนิดใหม่ซึ่งมีประโยชน์ในการรักษาโรค(กรรมวิธี) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2001 |